Van Riet Ivan相关文献与解析，生知库 | 链接生命科学的每一步

日期影响因子

Blood-derived cell-free DNA is a superior biomarker for noninvasive DNA methylation profiling in multiple myeloma

血液来源的游离DNA是多发性骨髓瘤无创DNA甲基化谱分析的优良生物标志物。

期刊:Blood Advances

影响因子:7.1

doi:10.1182/bloodadvances.2025016480

Heestermans, Robbe; Olsen, Catharina; Ameli, Shervine; Succari, Jana; Janssen, Toon; De Brouwer, Wouter; De Becker, Ann; Vande Broek, Isabelle; Bakkus, Marleen; Schots, Rik; De Bruyne, Elke; Van Riet, Ivan

多发性骨髓瘤

发表日期：2025

文献求助收藏

Oncolytic HSV-1 expressing FLT3L kills melanoma, glioblastoma, and pancreatic cancer cells in vitro and induces immunogenic cell death

表达FLT3L的溶瘤性HSV-1在体外可杀死黑色素瘤、胶质母细胞瘤和胰腺癌细胞，并诱导免疫原性细胞死亡

期刊:Molecular Therapy Oncology

影响因子:5.3

doi:10.1016/j.omton.2025.201031

Tuyaerts, Sandra; Geeraerts, Xenia; Reale, Alberto; Stevens, Latoya; Bertazzon, Giada; Brons, Jack; Janssen, Toon; Van Riet, Ivan; Calistri, Arianna; Neyns, Bart

细胞生物学

免疫/内分泌

发表日期：2025

文献求助收藏

Comparative Analysis of Bone Marrow, cfDNA and CTCs for NGS-Based Multiple Myeloma Detection: A Pilot Study Indicating the Potential of CTCs

基于NGS的多发性骨髓瘤检测中骨髓、cfDNA和CTC的比较分析：一项表明CTC潜力的初步研究

影响因子:4.4

doi:10.3390/cancers17244008

De Brouwer, Wouter; Heestermans, Robbe; Van der Straeten, Jona; Falise, Kiara; De Becker, Ann; Vande Broek, Isabelle; Schots, Rik; Bakkus, Marleen; Van Riet, Ivan

多发性骨髓瘤

发表日期：2025

文献求助收藏

Preclinical evaluation of antigen-sensitive B7-H3-targeting nanobody-based CAR-T cells in glioblastoma cautions for on-target, off-tumor toxicity

针对胶质母细胞瘤的抗原敏感型B7-H3靶向纳米抗体CAR-T细胞的临床前评估提示，可能存在靶向肿瘤外毒性。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2024-009110

Meeus, Fien; Funeh, Cyprine Neba; Awad, Robin Maximilian; Zeven, Katty; Autaers, Dorien; De Becker, Ann; Van Riet, Ivan; Goyvaerts, Cleo; Tuyaerts, Sandra; Neyns, Bart; Devoogdt, Nick; De Vlaeminck, Yannick; Breckpot, Karine

细胞生物学

免疫/内分泌

发表日期：2024

文献求助收藏

Intratumoral administration of the immunologic adjuvant AS01(B) in combination with autologous CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) myeloid dendritic cells plus ipilimumab and intravenous nivolumab in patients with refractory advanced melanoma

在难治性晚期黑色素瘤患者中，瘤内注射免疫佐剂AS01(B)联合自体CD1c(BDCA-1)(+)/CD141(BDCA-3)(+)髓系树突状细胞，并加用伊匹木单抗和静脉注射纳武利尤单抗。

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2023-008148

Tijtgat, Jens; Geeraerts, Xenia; Boisson, Anais; Stevens, Latoya; Vounckx, Manon; Dirven, Iris; Schwarze, Julia Katharina; Raeymaeckers, Steven; Forsyth, Ramses; Van Riet, Ivan; Tuyaerts, Sandra; Willard-Gallo, Karen; Neyns, Bart

树突状细胞

细胞生物学

树突状细胞

免疫/内分泌

发表日期：2024

文献求助收藏

The crosstalk between lung cancer and the bone marrow niche fuels emergency myelopoiesis

肺癌与骨髓微环境之间的相互作用促进了紧急髓系造血。

期刊:Frontiers in Immunology

影响因子:5.9

doi:10.3389/fimmu.2024.1397469

Calderon-Espinosa, Evelyn; De Ridder, Kirsten; Benoot, Thomas; Jansen, Yanina; Vanhonacker, Domien; Heestermans, Robbe; De Becker, Ann; Van Riet, Ivan; Decoster, Lore; Goyvaerts, Cleo

发表日期：2024

文献求助收藏

A randomized phase II clinical trial of stereotactic body radiation therapy (SBRT) and systemic pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) myeloid dendritic cells in solid tumors

一项随机 II 期临床试验，研究立体定向放射治疗 (SBRT) 联合全身性帕博利珠单抗，或不联合瘤内注射阿维鲁单抗/伊匹木单抗，以及 CD1c (BDCA-1)(+)/CD141 (BDCA-3)(+) 髓系树突状细胞治疗实体瘤的疗效。

期刊:Cancer Immunology Immunotherapy

影响因子:5.1

doi:10.1007/s00262-024-03751-0

Vounckx, Manon; Tijtgat, Jens; Stevens, Latoya; Dirven, Iris; Ilsen, Bart; Vandenbroucke, Frederik; Raeymaeckers, Steven; Vekens, Karolien; Forsyth, Ramses; Geeraerts, Xenia; Van Riet, Ivan; Schwarze, Julia Katharina; Tuyaerts, Sandra; Decoster, Lore; De Ridder, Mark; Dufait, Ines; Neyns, Bart

树突状细胞

细胞生物学

树突状细胞

免疫/内分泌

发表日期：2024

文献求助收藏

Liquid Biopsies as Non-Invasive Tools for Mutation Profiling in Multiple Myeloma: Application Potential, Challenges, and Opportunities

液体活检作为多发性骨髓瘤突变谱分析的非侵入性工具：应用潜力、挑战和机遇

期刊:International Journal of Molecular Sciences

影响因子:4.9

doi:10.3390/ijms25105208

Heestermans, Robbe; Schots, Rik; De Becker, Ann; Van Riet, Ivan

多发性骨髓瘤

发表日期：2024

文献求助收藏

Preanalytical variables influencing the interpretation and reporting of biological tests on blood samples of living and deceased donors for human body materials

影响活体和已故捐献者血液样本生物学检测结果解读和报告的分析前变量（用于人体材料检测）。

期刊:Cell and Tissue Banking

doi:10.1007/s10561-023-10106-z

Padalko, Elizaveta; Colenbie, Luc; Delforge, Alain; Ectors, Nadine; Guns, Johan; Imbert, Romain; Jansens, Hilde; Pirnay, Jean-Paul; Rodenbach, Marie-Pierre; Van Riet, Ivan; Vansteenbrugge, Anne; Verbeken, Gilbert; Baltes, Muriel; Beele, Hilde

发表日期：2024

文献求助收藏

Intratumoral administration of CD1c (BDCA-1)(+) and CD141 (BDCA-3)(+) myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial

在免疫检查点阻断治疗无效的晚期黑色素瘤患者中，瘤内注射 CD1c (BDCA-1)(+) 和 CD141 (BDCA-3)(+) 髓系树突状细胞联合 talimogene laherparepvec：一项 I 期临床试验

期刊:Journal for ImmunoTherapy of Cancer

影响因子:10.6

doi:10.1136/jitc-2022-005141

Schwarze, Julia Katharina; Tijtgat, Jens; Awada, Gil; Cras, Louise; Vasaturo, Angela; Bagnall, Christopher; Forsyth, Ramses; Dufait, Inès; Tuyaerts, Sandra; Van Riet, Ivan; Neyns, Bart

树突状细胞

细胞生物学

树突状细胞

免疫/内分泌

发表日期：2022

文献求助收藏